Eli Lilly's Weight Loss Drugs Spark Billion-Dollar Bidding War
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Pharmaceutical giants and startups race to develop next-generation weight-loss treatments as demand soars and market valuations skyrocket in this healthcare revolution.
Discover why skyrocketing classroom demands - not just salaries - are at the heart of Alberta's tense teacher negotiations and what it means for students.
Groundbreaking research suggests that exposure to artificial light at night could significantly increase your risk of developing cardiovascular disease and diabetes.
A hilarious historical mix-up involving ancient Roman rulers resulted in Australian high school seniors getting an unexpected reprieve from their final history exam. Discover how confusing two Roman leaders turned into every student's dream scenario.